Navigation Links
The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
Date:7/23/2008

- Nexavar is First Approved Systemic Therapy to Treat the Disease -

WAYNE, N.J. and EMERYVILLE, Calif., July 23 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that The New England Journal of Medicine published results of a Phase 3 trial demonstrating that Nexavar(R) (sorafenib) tablets decreased the absolute risk of death by 31 percent in patients with unresectable hepatocellular carcinoma (HCC), or liver cancer, versus patients who received placebo. This represents a 44 percent improvement in median overall survival for patients treated with Nexavar.

Based on the strength of these data, Nexavar was approved for HCC by the European Agency for the Evaluation of Medicinal Products (EMEA) and by the U.S. Food and Drug Administration (FDA) in October and November 2007, respectively.

"Despite advances in the management of many other cancers, liver cancer has remained a treatment challenge, due to a lack of systemic therapies to extend life and limited opportunity for surgical intervention," said Dr. Josep M. Llovet, co-principal investigator of the study and professor of research, Barcelona Clinic Liver Cancer (BCLC) Group, IDIBAPS, Liver Unit, Hospital Clinic Barcelona; director of research, HCC Program, associate professor of Medicine, Mount Sinai School of Medicine, New York. "This landmark study reflects a new systemic standard of care using Nexavar in the first-line management of liver cancer."

"The number of lives lost to liver cancer continues to increase globally, due to the prevalence of hepatitis B and C infections," said Jordi Bruix, co-principal investigator and director of the Barcelona Clinic Liver Cancer (BCLC) Group; senior consultant, Liver Unit, Hospital Clinic of Barcelona. "We are encouraged that there is a new treatment option available for liver cancer that has clearly demonstrated a survival benefit in this patient population."

The in
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals; Onyx Pharmaceuticals,Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
2. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
3. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
4. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
5. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
6. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
7. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
8. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
9. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
11. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015 Dynatronics Corporation (NASDAQ: DYNT ) today announced ... products. This approval allows the company to sell these products in ... world. "Receiving the CE Mark represents the achievement of ... H. Cullimore Jr. , president and CEO of Dynatronics. "Over the ... China , Japan , ...
(Date:7/27/2015)... and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the ... commercializing proven cancer therapies in new orphan drug ... from institutional and accredited investors for a registered ... common stock and 3.35 million common stock purchase ...
(Date:7/27/2015)... DUBLIN , July 20, 2015 ... the addition of the "Key Pharma News ... This acquisition bolsters Gilead Sciences, burgeoning oncology ... Gilead will make further oncology deals in 2015, ... end of 2016. Key Pharma ...
Breaking Medicine Technology:Dynatronics Awarded CE Mark Approval for Its Solaris Products 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3
... BRISBANE, Calif., March 3, 2011 InterMune, Inc. (Nasdaq: ... Commission (EC) has granted marketing authorization for Esbriet ® ... treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), ... marketing of Esbriet in all 27 EU member states, ...
... ("CTI") (Nasdaq and MTA: CTIC) today announced that it has ... ("OND") in Maryland and presented its arguments supporting the Company,s ... ("NDA") 22-481 support the conclusion that pixantrone is effective for ... our appeal.  While we understand disputes of this type are ...
Cached Medicine Technology:InterMune Receives European Union Approval for Esbriet® (pirfenidone) 2InterMune Receives European Union Approval for Esbriet® (pirfenidone) 3InterMune Receives European Union Approval for Esbriet® (pirfenidone) 4InterMune Receives European Union Approval for Esbriet® (pirfenidone) 5InterMune Receives European Union Approval for Esbriet® (pirfenidone) 6FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 2FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 3
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of ... Professional Woman of the Year. Ms. Baum-Lappe is recognized with this prestigious distinction ... in the country, spanning virtually every industry and profession, the National Association that ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... From Step One, **FDAnews Webinar**, Aug. 13, 2015 — 1:30 p.m. – 3:00 ... one of the first things FDA investigators will look at during an inspection. ...
(Date:7/27/2015)... ... July 27, 2015 , ... On July 14, 2015, ... Common Skin Issues,” describes common skin issues such as stretch marks , ... dermatologists to treat them. The treatment options listed include lasers, ultrasound, radio frequency, Botox, ...
(Date:7/27/2015)... , ... July 27, 2015 , ... North Central Surgical ... , The center invites all those prospective joint-replacement patients, along with their friends ... of each month, with Monday classes (Aug 6, Sept 8 [Tue due to Labor ...
(Date:7/27/2015)... York, NY (PRWEB) , ... July 27, 2015 , ... ... American tour. He will be performing for one additional night at each of ... add promo/coupon code DAVID-GILMOUR-2016 for added savings. , David Gilmour’s 2016 North America tour ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 2Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 3Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 4Health News:The Latest Treatment Options for Seven Common Skin Issues 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Cheap David Gilmour Tickets at Madison Square Garden (MSG), Air Canada Center, United Center and Hollywood Bowl: Additional Dates for David Gilmour Go On Sale Today 2
... presented at the 71st Annual Scientific Meeting of ... endoscopic surgical// techniques – entering the abdomen through ... – can be successful in both bovine and ... gastroplasty for morbid obesity showed signs of initial ...
... recent study conducted at Stanford University published in American Journal ... at hand to help those// suffering from elbow tendonitis ... the possibility of a surgery to alleviate the suffering. It’s ... racquets on grass or clay courts. This ailment starts with ...
... risk of cancer is high for obese people. During studies conducted ... of weight it helped cut// down risk of some cancers, even ... liposuction was enough, as revealed in the mice study. ... cut off the superfluous fat from some mice and subjected them ...
... has been noted worldwide that a stay at any health ... infections which can complicate matters causing discomfort and// increased added ... one-tenth of patients in Canada are forced to stay longer ... during their stay there.Such infections picked up during a course ...
... nestled near the Similipal wildlife sanctuary in Orissa's Mayurbhanj ... ,"We are dying of government apathy," lamented ... are locked inside the forests." If the administration and ... well be wiped out, according to Grassroots Features. ...
... conducted by Irish Examiner/Landsdowne Market Research was an eye ... Ireland are unhappy with the maternal// services offered in the ... , ,The research has revealed that almost 63% ... two years were displeased with several aspects of the antenatal ...
Cached Medicine News:Health News:New, Minimally-Invasive Surgery for the Morbidly Obese 2Health News:New, Minimally-Invasive Surgery for the Morbidly Obese 3Health News:Tribals in the Brink of Extinction due to Malnutrition and Diseases 2Health News:Tribals in the Brink of Extinction due to Malnutrition and Diseases 3Health News:'Ire' of Irish Moms pained over maternity services in Ireland. 2
... The REFLEXION 1st MPJ IMPLANT SYSTEM ... the primary reconstruction of the 1st metatarsal ... traumatic arthritis or revision of a previous ... achieve three goals: pain relief, superior function ...
... The hands play an important part in ... impairments and rheumatic changes can cause severe ... of the finger-joint prostheses was to produce ... the natural function as nearly possible.,The cementless ...
... The OSTEOMED 3.0/4.0mm CANNULATED SCREW SYSTEM ... Orthopedic Hand surgeon and Podiatrist, can be ... fusions. The system features two simplified ... Both screw sizes utilize one unique set ...
... the lower extremity for prepping before hip or ... procedures and particularly helpful for supporting the leg ... By holding the foot/ankle in an externally rotated ... which helps eliminate the need for manual support.,The ...
Medicine Products: